Skip to main content
recep.adiyaman
Vision About Experience Education Skills Publications Tools Newsletter Updates Podcasts Blog Contact CV Subscribe
All Issues
Older Newer
Daily Signal June 02, 2026 · 9 min read

Issue #121: AI-driven drug-target interaction prediction: current progress, challenges, and future roadmap for precision medicine.

Protein Design Digest #121: Tocotrienol as a multi-target inhibitor of ICAM-1, VCAM-1, and E-selecti…

Share X LinkedIn
Protein Design Daily

Building something in Protein Design?

I love collaborating on new challenges. Let's build together.

LinkedIn Email

Subscribe to Protein Design Digest

Daily curated signals from arXiv, PubMed, and BioRxiv.

Signal of the Day

AI-driven drug-target interaction prediction: current progress, challenges, and future roadmap for precision medicine.

Drug-target interactions (DTIs) are fundamental to drug discovery, development, and repositioning. However, experimental methods for DTI identification are often constrained by high costs, time demands, and scalability issues, prompting a shift toward computational approaches. This review systematically explores recent advancements in computational DTI prediction, encompassing ligand-based, target-based, network-based, machine learning (ML), deep learning (DL), and hybrid multi-omics models. Ligand-based techniques, such as QSAR and pharmacophore modeling, offer structure-activity insights but require known ligands. Target-based methods rely on molecular docking and binding site prediction, yet often suffer from incomplete or unknown protein structures. Network-based strategies utilize bipartite and heterogeneous graphs integrated with protein-protein interaction (PPI) networks to infer novel DTIs. ML and DL methods especially graph neural networks and Transformer-based models have significantly improved prediction accuracy by leveraging chemical, biological, and omics features. Notably, hybrid models that integrate genomics, transcriptomics, proteomics, and interactomics data offer a systems biology perspective, enabling context-specific and personalized predictions. Key databases, like DrugBank, ChEMBL, and Binding DB, and computational tools such as Deep Purpose, NeoDTI, and FusionDTI, exemplify the latest advances in DTI prediction. Validation strategies are discussed through contemporary case studies. While substantial progress has been made, key challenges remain, including data sparsity, model interpretability, and generalization. Looking forward, emerging trends such as federated learning, AlphaFold-based docking, and quantum simulations are poised to further transform the field. This review emphasizes the importance of interdisciplinary integration and ethical frameworks, charting a roadmap for future DTI research and its translational applications in precision medicine.

Why this matters:

Also Worth Reading

Exploring the mechanism of saffron in treating viral myocarditis using network pharmacology and molecular docking.

Viral myocarditis (VM) is a cardiovascular disorder that can lead to heart failure and cardiogenic shock. Saffron, a traditional Chinese medicinal herb, has shown therapeutic potential against VM in numerous studies. However, the mechanisms through which saffron exerts its effects on VM remain poorly understood. Thus, this study aimed to elucidate the active compounds, molecular targets, and signaling pathways involved in saffron’s therapeutic action against VM by employing network pharmacology and molecular docking approaches. The active compounds and corresponding targets of saffron were retrieved from the Traditional Chinese Medicine Systems Pharmacology database. VM-associated targets were sourced from the GeneCards database. Overlapping targets between saffron and VM were then identified. Protein-protein interaction networks were established and analyzed utilizing the STRING platform and Cytoscape software to determine core targets. Furthermore, gene ontology and Kyoto encyclopedia of genes and genomes enrichment analyses were carried out utilizing Bioconductor in R to explore the potential biological activities and signaling pathways through which saffron may act against VM. Finally, molecular docking and model visualization were carried out using AutoDock Tools and PyMOL open-source software. From the database, we identified 4 active compounds in saffron with potential effects against VM: crocetin, isorhamnetin, kaempferol, and quercetin. A total of 60 corresponding targets were observed, with TNF, IL-6, IL-1β, CXCL8, and JUN emerging as core targets. Kyoto encyclopedia of genes and genomes enrichment analysis revealed 155 regulatory signaling pathways, among which the TNF, AGE-RAGE, and IL-17 signaling pathways, lipid metabolism, and atherosclerosis were the most prominent. Molecular docking results indicated that quercetin showed the strongest binding affinity toward IL-1β and CXCL8. The therapeutic effect of saffron against VM is not driven by a single factor, but rather involves multiple active compounds, targets, and signaling pathways.

Investigation of in vitro anticancer and antioxidant activities of various extracts of Bayramiç Beyazı nectarine, and molecular docking, molecular dynamics simulation, and protein-protein interaction network

Nectarine (Prunus persica var. nucipersica), due to its high phenolic content and antioxidant properties, holds significance for human health. The aim of this study was to evaluate the in vitro anticancer and antioxidant effects of the extracts obtained from the fruit and kernel of “Bayramiç Beyazı” nectarine, a geographically indicated fruit grown in Bayramiç district of Çanakkale. The anticancer effects of the methanol and aqueous ethanol extracts were evaluated on breast and colon cancer cell lines. Apoptotic fragmentation and mitochondrial membrane potential of fruit and kernel extracts were examined under fluorescence microscopy. Antioxidant activity and phenolic content were determined using DPPH, ABTS, and Folin-Ciocalteu (F-C) methods, respectively. Kernel extract has the highest antioxidant activity (DPPH IC₅₀= 0.15 ± 0.001 mg/mL). The fruit methanol, aqueous ethanol, and kernel aqueous ethanol extracts significantly reduced the fluorescent intensity of the cells. A combination study was conducted between the extracts and doxorubicin. Molecular docking and molecular dynamics (MD) simulation studies of some of the identified components were performed using the Glide/SP and Desmond against a drug target PRK1. The highest binding affinity with quercetin for targeting PRK1 was calculated as -8.789 kcal/mol. The average RMSD values were calculated between 3.43 ± 0.31 and 2.22 ± 0.30 Å throughout 500 ns MD simulations. A protein-protein interaction network analysis was performed for PRK1 using a systems biology approach to identify the highest scoring predicted proteins such as RHOA, MAP2K3, and MEFV. The investigation of the in vitro anticancer effects of “Bayramiç Beyazı” extracts and combined in silico analyses were carried out for the first time, and the outcomes of this study have promising potential for future studies.

Integrating Conformational Sampling and Siamese Learning to Predict Mutation-Induced Binding Affinity Changes in Abelson Tyrosine Kinase and Its Ligands.

Predicting the impact of mutations on protein-ligand binding affinity is crucial in drug discovery, particularly in addressing drug resistance and repurposing existing drugs. Conventional structure-based methods are often limited by their reliance on static cocrystal structures. To address this, we integrate AlphaFold 2 (AF2) subsampling with a Siamese neural network to predict mutation-induced changes in the relative binding affinity. By leveraging AF2 subsampling, we generated conformational ensembles for Abelson tyrosine kinase (ABL) mutants, shifting the paradigm from single-point predictions to an ensemble-based approach that accounts for intrinsic structural flexibility. Furthermore, we augmented the data set by pairing the generated conformations with reference states, followed by the identification of structurally relevant states via a most probable distribution analysis. To facilitate relative affinity prediction, we developed SIGMA-Net (Siamese structure and graph-aware multistructural affinity prediction network), which was employed to discern features between wild-type and mutant states, enabling free-energy predictions with chemically meaningful accuracy. Benchmarking on the tyrosine kinase inhibitors (TKI) data set and the refined set of PDBbind, our proposed approach achieves higher correlation coefficients for five of six TKI molecules across 31 ABL mutants, outperforming molecular docking and trichannel graph network (TriG-Net). By integrating conformational sampling with Siamese learning, our method enhances both the predictive accuracy and robustness. It achieves absolute binding free energy (ABFE) prediction performance comparable to that of state-of-the-art models such as Boltz-2, whereas Boltz-2 demonstrates better performance in relative binding free energy (RBFE) prediction in the evaluated systems. This framework effectively transcends the limitations of static structure dependence, providing a transferable solution for modeling protein-ligand interactions in highly flexible drug targets.

Research & AI Updates

From the Industry

Quick Reads

Integrated computational evaluation of flavonoids from Artemisia campestris L. as FLT3 inhibitors: molecular docking, dynamics, ADMET, DFT, and topological (ELF, LOL) insights.

Mutations in FLT3 are found in around one third of acute myeloid leukemia (AML) cases and contribute significantly to disease progression, making this kinase a key therapeutic target. Read more →

ProtFormer-Site: Ultra-fast and Accurate Prediction of Protein-Protein Interaction Sites with Protein Language Model.

Identifying protein-protein interaction (PPI) sites is crucial for predicting protein function, uncovering disease mechanisms, and designing drugs. Read more →

Exploring the potential targets and mechanisms of artemisinin in the treatment of diabetic kidney disease using network pharmacology and molecular docking.

Diabetic kidney disease (DKD) is a secondary glomerular disease caused by diabetes, and its incidence is increasing annually. Read more →

Integrated LC-MS/MS profiling, network pharmacology, molecular docking, and enzyme inhibition assays reveal the antidiabetic potential of <i>Mitragyna speciosa</i>.

Mitragyna speciosa has gained attention as a medicinal plant with potential metabolic benefits, yet its antidiabetic mechanism remains unclear. Read more →

Molecular Dynamics Simulations: Principles, Algorithms, and Emerging Applications

Molecular dynamics (MD) simulation is a fundamental technique for resolving biomolecular structures and functions at atomic resolution. Read more →

AI-driven drug-target interaction prediction: current progress, challenges, and future roadmap for precision medicine.

Drug-target interactions (DTIs) are fundamental to drug discovery, development, and repositioning. Read more →

Revisiting BACE-1: How Machine Learning and Molecular Dynamics Unveiled Potential Anti-Alzheimer’s Activity of a Cysteinyl Sulfoxide Derivative

Beta Secretase (BACE-1) is a well-validated target for Alzheimer’s therapies, but have seen attrition in drug development. Read more →

Fragment-based discovery of TopBP1 inhibitors integrated with AI-driven molecular docking.

DNA topoisomerase IIβ-binding protein 1 (TopBP1) converges on multiple oncogenic pathways, e.g., Rb, p53, and PI3K/Akt, which are hallmarks of most cancer progression. Read more →

Pipeline Tip

Employ HADDOCK for ambiguous restraints in protein-protein docking.

Resources & Tools

Deep learning is not a magic wand, but a powerful lens for structural biology. — Recep Adiyaman

BS HF DK